Evidence map›Paper›PMID 35903332›Full record

ArticleFrontiers in pharmacology2022

Mechanistic Research for the Student or Educator (Part II of II).

Rehana K Leak, James B Schreiber

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Rehana K LeakGraduate School of Pharmaceutical Sciences, Duquesne University, Pittsburgh,, PA, United States.
James B SchreiberSchool of Nursing Duquesne University, Pittsburgh, PA, United States.

Funding

DNA repair and alpha-synucleinopathy in Lewy body disordersR21NS112671 · NINDS · DUQUESNE UNIVERSITY · PI LEAK, REHANA KHAN · 2020 to 2020
$408k
Impact of N-acetyl cysteine ethyl ester on a-synuclein pathology in the olfactory systemR15NS093539 · NINDS · DUQUESNE UNIVERSITY · PI LEAK, REHANA KHAN · 2015 to 2015
$383k
NINDS NIH HHS R15 NS093539NINDS NIH HHS R21 NS112671
6 · The paper itself

Abstract

This two-part series describes how to test hypotheses on molecular mechanisms that underlie biological phenomena, using preclinical drug testing as a simplified example. While pursuing drug testing in preclinical research, students will need to understand the limitations of descriptive as well as mechanistic studies. The former does not identify any causal links between two or more variables; it identifies the presence or absence of correlations. Parts I and II of this educational series encourage the student to 1) ensure the sensitivity and specificity of their measurements, 2) establish or optimize an appropriate disease model, 3) find pharmaceutical drug doses/concentrations that interfere with experimental disease processes, 4) leverage the literature and exploratory datasets to craft a mechanism-oriented hypothesis on drug binding and downstream effects, 5) and design a full-factorial experiment to test the hypothesis

Indexed as

biologybiomedicinehypothesismechanisticpharmaceuticalphysiologypreclinical

Identifiers

PMID35903332
PMCPMC9315264

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.